Familial Hypercholesterolemia
Conditions
Interventions
Nutritional intervention through amartphnoe application(for 12 month)
Standard nutritional counseling
Sponsors
Kanazawa University Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: who is applicable to all of those Pateints with FH regarldess of medical therapies, gender, and ASCVD Disgnostic criteria is used by Japan Atherosclerosis Society 2017 LDL-C 100 mg/dL or over age 20 years or over who can used smartphone app who provide written informed consent to this study
Exclusion criteria
Exclusion criteria: who is applicable to one of those diabetes, malignant hypertension, secondary hypertension under insulin therapy Female with pregnancy or expected eGFR< 45ml/min/1.73m2 severe Liver dysfunction within 1 year from myocardial infarction or stroke allergy and/or nuder steroid pancreatitis (active or history) under treatment of malignancies Patients whose doctors in charge consider him/her inappropriate to participate
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Absolute change of LDL-C from baseline (at 12 months) | — |
Secondary
| Measure | Time frame |
|---|---|
| Fasting glucose Cost Blood pressure Serum lipids (TCHO, TG, HDL-C) Urin albmin New onset of diabetes Changes in lipid-lowering therapies Frequency of use of application Absolute LDL-C change due to the change of nutritional intake | — |
Countries
Japan
Contacts
Public ContactHayato Tada
Kanazawa University Hospital Department of Cardiology
Outcome results
None listed